Talevski, J. http://orcid.org/0000-0001-9180-8758
Sanders, K. M.
Lal, A.
Watts, J. J.
Beauchamp, A.
Duque, G.
Borgström, F.
Kanis, J. A.
Svedbom, A.
Brennan-Olsen, S. L.
Funding for this research was provided by:
National Health and Medical Research Council
Amgen
Eli Lilly and Company
Medtronic
Novartis
Sanofi
Servier
Pfizer
Deakin University
Article History
Received: 3 April 2022
Accepted: 1 June 2022
First Online: 15 June 2022
Declarations
:
: None.
: ICUROS adhered to the Declaration of Helsinki and was approved by the relevant research ethics committees in each country. Access to ICUROS data was approved from the principal investigators in each country (excluding the USA) and Melbourne Health Human Research Ethics Committee (2010.115).
: Informed consent was obtained from all individual patients included in the study and all study patients could withdraw from the study at any time at their own request.
: All authors approved the final manuscript for publication.